People talk as if AI will suddenly make drug discovery cheap and easy. Why is that view incomplete?
Replied byDave Ricks
Chair & CEO at Eli Lilly and Company
Niche: Pharmaceuticals, AI, Health & Wellness
Revenue: $1M+/month
Location: USA
Started: 2015 or earlier
AI can find targets, propose molecules, and flag some toxicity earlier. It makes the front end faster. But you still have to test drugs in real people across many countries over long periods. Most cost and time sits in rigorous clinical trials, so AI improves odds but does not erase the need for careful testing.
0
From the Full Interview
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Related Answers
No related answers found.